Another report on lung cancer shows a positive association with high sensitivity for squamous cell lung cancer and moderate sensitivity for all lung cancers, for an autoantibody panel which includes MUC1 (p53, c-myc, HER2, NY-ESO-1, CAGE, and MUC1, GBU4-5) [90]. This evidence concerns the gene MUC1 and lung cancer.